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INTRODUCTION:  We  report  a  rare case  of invasive  micropapillary  carcinoma  in  the male  breast.
PRESENTATION OF  CASE: A  63-year-old  man  was referred  to  our  hospital  for investigation  of a  left breast
tumor,  which  could  be palpated  in  the  upper  lateral  quadrant  of  the  left nipple-areola  complex.  The
tumor  invaded  the  areola  skin.  Ultrasonography  showed  a 14.8  × 15.0  ×  12.4  mm  low  echoic  mass,  with
an  irregular  lobulated  border.  Core  needle  biopsy  indicated  invasive  ductal  carcinoma,  but  the  subtype
could  not  be accurately  determined.  Mastectomy  with  axillary  lymph  node  dissection  was  performed.
Pathological  examination  indicated  invasive  micropapillary  carcinoma,  no lymph  node  metastasis,  and  a
nuclear  grade  of 2.  Immunohistochemical  examination  showed  positive  staining  for  estrogen  and  proges-
terone  receptors,  but negative  staining  for  HER2.  The  Ki67  index  was  5%.  Tamoxifen  was  administered,
and  recurrence  has  not  been  noted  for 1 year.
DISCUSSION: Women’s  IMPC  generally  shows  a high  HER2  positivity  rate.  However,  HER2  positivity  was
noted  in  only  1 male  patient  with  IMPC  (14%)  according  to  our literature  review.  Furthermore,  in all
cases  of  the mixed  type  that  were  reviewed,  IMPC  was  associated  with  papillotubular  carcinoma.  These
ﬁndings  may  be speciﬁc  to IMPC  in  male patients.
CONCLUSION: IMPC  is associated  with  a high  rate  of lymph  node  metastasis  or recurrence  and  advanced
vessel  invasion,  aggressive  adjuvant  chemotherapy  following  surgical  resection  should  be  selected  for
patients  with  IMPC.
© 2013 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd. 
 . Introduction
Invasive micropapillary carcinoma (IMPC) is a subtype of inva-
ive ductal carcinoma, ﬁrst reported by Siriaunkgul et al. [1] in
993. IMPC accounts for 3.8–5.9% of all cases of breast cancer and
ccurs most frequently in women aged 50–60 years [2–5]. It is
haracterized by a high incidence of lymphovascular invasion and
ymph node metastasis, resulting in poor prognosis [2–5]. Here, we
escribe a rare case of IMPC in a male patient who did not show
ymph node metastasis or lymphovascular invasion and review the
elevant literature..  Case report
A 63-year-old man  with paralysis of the extremities due
o spinal injury was referred to our hospital for investigation
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ttp://dx.doi.org/10.1016/j.ijscr.2013.09.001and treatment of a left breast tumor. On physical examina-
tion, a hard, elastic tumor was palpated in the upper lateral
quadrant of the left nipple-areola complex and the tumor
was found to invade the areola skin (Fig. 1). Ultrasonogra-
phy showed a 14.8 mm × 15.0 mm × 12.4 mm irregularly shaped
well-circumscribed, solid mass with an indented margin and
heterogeneous internal echo (Fig. 2). However, posterior echo
enhancement was  not observed. Contrast-enhanced computed
tomography showed an approximately 13-mm nodular lesion
below the nipple. The area surrounding the mass appeared fuzzy,
indicating tumor invasion of the nipple. Neither lymph node metas-
tases nor distal metastasis was noted. Core needle biopsy revealed
clusters of atypical cells, indicating a diagnosis of invasive ductal
carcinoma; however, accurate determination of the pathological
subtype before surgery was  not possible. We tried to detect sentinel
lymphnode by near-infrared ﬂuorescence imaging system, how-
ever we  could not do it. Therefore we  performed mastectomy with
axillary lymphnode dissection. Examination of the cut surface of the
Open access under CC BY-NC-ND license.resected specimen showed that the tumor was solid with a spicu-
lated border. It invaded the nipple and the skin (Fig. 3). Pathological
examination revealed actively proliferating cancer cells arranged
in micropapillary nests. The cells were ﬂoating within clear spaces
lined by delicate strands of stroma (Fig. 4a). Micropapillary nests
were composed of dozens of cancer cells without ﬁbrovascular
s Ltd. Open access under CC BY-NC-ND license. 
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Fig. 1. Physical examination ﬁndings. A hard, elastic tumor was palpable in the
upper lateral quadrant of the left nipple-areola complex, and the tumor had invaded
the areola skin (arrow).
Fig. 2. Ultrasonography features. Ultrasonography showed an irregularly shaped,
well-circumscribed, solid mass with an indented margin and heterogeneous internal
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Fig. 3. Resected specimen examination. Examination of the cut surface of the
resected specimen showed that the tumor was  solid with a spiculated border. The
tumor was  observed to have invaded the nipple and the skin (circle).cho. The tumor was 14.8 mm × 15.0 mm × 12.4 mm.
ores and were surrounded by empty, clear spaces lined with deli-
ate strands of ﬁbrocollagenous stroma (Fig. 4b). These ﬁndings led
o a diagnosis of invasive micropapillary carcinoma. The tumor was
 mixed type, and papillotubular carcinoma accounted for approx-
mately 40% of the tumor (Fig. 4c). Lymph node metastasis was
ot detected, and the nuclear grade was classiﬁed as 2. Immuno-
istochemical examination showed positive staining for estrogen
ER) and progesterone (PgR) receptors, but negative staining for
ER2. The Ki67 index was 5%. Tamoxifen has been administered,
nd no recurrence has been noted for approximately 1 year after
urgery.
. Discussion
IMPC was recently assigned a separate classiﬁcation according
o the World Health Organization (WHO) histological classiﬁcation
f breast tumors (2003) [6] and the general rules for clinical and
athological recording of breast cancer (16th edition, 2008) [7] in
apan. IMPC in male patients is very rare, with only 7 cases with
omplete details being described in the literature as per a Medline
nd Japan Medical Abstracts Society search (Table 1) [8–14]. Theaverage age of male patients with IMPC is 69.8 years, slightly higher
than that of female patients with IMPC.
The reported pathological characteristics of IMPC include can-
cer cells ﬂoating within clear spaces lined by delicate strands
of stroma and micropapillary nests composed of dozens of can-
cer cells without ﬁbrovascular cores surrounded by empty, clear
spaces lined with delicate strands of ﬁbrocollagenous stroma [1–7].
We were unable to detect these features in the case reported
here; however, cancer cells frequently show reversed polarity, a
cytological morphology referred to as an inside-out growth pat-
tern.
The incidence of axillary node metastasis in IMPC is reported
to be 67–90% [2–5], and 64% of patients with lymph node metas-
tasis have more than 3 lymph nodes [5]. IMPC is also associated
with a high rate of local recurrence. Tresserra et al. reported that
27% of IMPC patients who  underwent lumpectomy showed local
recurrence, although 75% of these patients had received radiation
treatment [15]. Authors concluded that lumpectomy is inadequate
for local control even when complemented with radiotherapy.
Our patient did not show recurrence during a follow-up period of
approximately 1 year after mastectomy with axillary lymph node
dissection. Accordingly, we suggest that radical mastectomy with
complete axillary dissection be performed when IMPC is diagnosed
on the basis of preoperative biopsy ﬁndings. Some studies sug-
gest that IMPC is associated with a poorer prognosis than other
invasive ductal carcinomas. Pettinato et al. reported that 49% of
patients with IMPC died of distant metastasis at a mean of 5.2
years (range, 1–10.5 years) after initial diagnosis [5]. IMPC often
occurs in association with other types of breast carcinoma. Cases
in which IMPC accounted for more than 50% of the tumor were
associated with a signiﬁcantly higher rate of lymph node metas-
tasis and recurrence at 5 years and a poorer prognosis than cases
in which IMPC accounted for less 50% of the tumor [16]. In fact,
all male patients with pure IMPC reported in the literature died of
recurrence or distant metastasis (Table 1). In our case, the IMPC
component accounted for 60% of the lesion. Accordingly, the pro-
portion of the IMPC component might be an important factor for
prognosis.
Luna-More et al. reported ER, PgR, and HER2 positivity rates of
71.3%, 48.3%, and 51%, respectively [17]. Pettinato also described
a high HER2 positivity rate (95%) [5]. However, HER2 positiv-
ity was noted in only 1 male patient with IMPC (14%) according
to our literature review. Furthermore, in all cases of the mixed
type that were reviewed, IMPC was associated with papillotubu-
lar carcinoma. These ﬁndings may  be speciﬁc to IMPC in male
patients.
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Fig. 4. Pathological examination ﬁndings. The actively proliferating cancer cells formed micropapillary nests. The cells were ﬂoating within clear spaces lined by delicate
strands  of stroma (a: hematoxylin-eosin [HE], ×100). The micropapillary nests were composed of dozens of cancer cells without ﬁbrovascular cores and were surrounded
by  empty, clear spaces lined with delicate strands of ﬁbrocollagenous stroma (b: HE, ×200). The tumor was of the mixed type with an IMPC component and a papillotubular
carcinoma component (c: HE, ×100).
Table 1
Clinicopathological data of 8 cases of invasive micropapillary carcinoma of the breast in a male patient.
Age IMPC
component
Other
component
ER PgR HER2 Ki67 Number of
positive
lymph nodes
Adjuvant
therapy
Prognosis Recurrences
Erhan et al. [8] 66 100% N/A Negative Negative Positive 60% No data CEF Dead (3
months)
Lung
metastasis
Nomura et al. [9] 85 70% Papillotubular Positive Positive Negative 49.70% 4 TAM Alive (1 year)
Shimizu et al. [10] 77 100% N/A Positive Negative Negative No data 22 5′DFUR/TAM Dead (22
months)
Local
recurrence
Minoshima et al. [11] 56 67% Papillotubular,
scirrhous
Positive Positive Negative 35% 1 FEC → DOC → TAM Alive (22
months)
Kawauchi et al. [12] 57 No data N/A Positive Positive Negative No data 0 TAM No data
Nagai  et al. [13] 73 80% Papillotubular Negative Negative Negative No data 0 No data No data
Akamatsu et al. [14] 81 90% Papillotubular Positive Positive No data No data No data No data No data
Present case 63 60% Papillotubular Positive Positive Negative 5% 0 TAM Alive (1 year)
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None., cyclophosphamide; E, epirubicin; F, 5-ﬂuorouracil; TAM, tamoxifen; DOC, doceta
. Conclusion
Little is known about the effects of endocrine therapy,
hemotherapy, molecular targeted therapy, or radiation on IMPC,
nd the optimal adjuvant therapy has not yet been established yet.
ecause of the absence of lymph node metastasis and a molecular
ubtype of luminal A, we only administered tamoxifen and reg-
larly followed-up our patient. Furthermore, because our patient
as physically challenged, he did not wish to receive chemother-
py. However, given that IMPC is associated with a high rate of
ymph node metastasis or recurrence and advanced vessel invasion,
ggressive adjuvant chemotherapy following surgical resection
hould be selected for patients with IMPC.FUR, deoxyﬂuorouridine.
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